News

Navigated laser photocoagulator with precise retinal targeting enables highly accurate perifoveal laser application and resulted in no foveal damage.

Lens retrodots and vacuoles are positively linked with a 10-year incidence of cataract surgery.

Photodynamic therapy reduces subretinal fluid (SRF) in patients with symptomatic choroidal nevus with serous macular detachment.

Using blue light-filtering IOLs, as opposed to UV-only filtering non-toric IOLs, produces a significantly greater reduction in glare disability when driving.

Orally administered ethanol is secreted into tears and can cause the development of ocular surface diseases.

Epiphora secondary to punctal and canalicular stenosis is successfully managed by mini-monoka punctocanaliculoplasty.

Dry eye is common in children with juvenile rheumatoid arthritis (JRA).

Conjunctival microcysts density and surface area increases after canaloplasty in glaucomatous eyes.

Real-world experience with EasyScan system confirms preliminary clinical results

The ophthalmic artery (OA) of open-angle glaucoma (OAG) has an increased resistance to blood flow compared with posterior ciliiary artery (PCA) patients.

Ultra-widefield SLO versus onsite mydriatic ophthalmologic examination

Femtosecond platform

According to Professor Albert Augustin, OCT is mandatory in research and very helpful in avoiding unnecessary treatment.

Comprehensive analysis helps with diagnosis and follow-up

The future of glaucoma diagnosis and management

OCT can guide paractioners to the correct procedure and prognosis

Preventing inflammation is still necessary despite surgical innovations

The future of OCT seems almost limitless and for Dr Jay S. Duker, many more new innovations are expected.

OCT has come a long way since its introduction but there is still room for improvement.

Guidelines can be adapted to everyday practice with high rate of satisfaction among patients

Improved imagery could help physicians learn more about diseases and treatment response

Faster technology to be able to screen for diabetic retinopathy is a requirement as the disease is becoming more prevalent.

Therapy for chronic ocular allergy a major focus for drug development

Ranibizumab well tolerated by patients; results maintained better for branch occlusion

Dr Marcus Kernt tackles the subject of diabetic retinopathy (DR) screening using ultra-widefield scanning laser ophthalmoscopy (SLO), which he believes is a valid alternative to the current gold standard.

A more dynamic therapeutic approach is needed

Advances in technology should improve current OCT shortcomings

Male gender, younger age related to IOP elevation after RVO treatment, study finds

Iluvien, an intravitreal implant for the treatment of chronic diabetic macula oedema (DME) developed by Alimera Sciences, has been granted market authorization by the Austrian Agency for Health and Food Safety.

OptiMedica's Catalys precision laser system has been given the CE mark of approval for corneal incisions.